Nature published new work on Robin, a multi-agent system designed to automate the scientific discovery loop for experimental biology. The system integrates literature-search agents with data-analysis agents to generate hypotheses, propose experiments, interpret results, and iteratively refine next directions. Using Robin, the authors reported discovery of therapeutic candidates in dry age-related macular degeneration, including in vitro validation for ripasudil and KL001, and followed up with mechanism analysis involving ABCA1 upregulation from RNA-seq. The publication positions Robin as a step toward semi-autonomous, loop-based discovery in a lab-in-the-loop framework, aiming to reduce the manual throughput bottlenecks that slow candidate identification.